Clinical Trials in Texas

Showing 5401-5420 of 15,101 trials

Investigator Initiated Trial to Study Duobrii® Lotion in the Treatment of Mild Plaque Psoriasis in Adults

NCT05203315

This study seeks to evaluate the safety, tolerability, and efficacy of topical Duobrii® Lotion in adult subjects with mild plaque psoriasis.

Plaque Psoriasis

Austin Institute for Clinical Research21 participantsStarted Jan 2022

Houston, Texas, United States • Pflugerville, Texas, United States

COMPLETEDPhase 243 miles

Proof of Concept Study to Access Superficial Basal Cell Carcinoma in Adults

NCT05713760

This is a Phase 2, Single-Arm, Open-Label, Single Center, Proof of Concept Study to Assess Efficacy and Safety of Tirbanibulin Ointment 1% in Adult Subjects with superficial basal cell carcinoma (sBCC) on the neck, trunk, or extremities (excluding, axilla, anogenital, and face/scalp).

Superficial Basal Cell Carcinoma

Austin Institute for Clinical Research5 participantsStarted Apr 2023

Pflugerville, Texas, United States

COMPLETEDNA43 miles

Placebo-Controlled Study Assessing the Use of a Novel Exfoliative Serum With A Chemical Peel to Improve Photodamage in Adults

NCT05908825

This is a split-face, double-blind, placebo-controlled study assessing the use of a novel exfoliative serum with a chemical peel to improve photodamage in healthy female subjects between the ages of 30 and 65 years, inclusive, with Fitzpatrick skin types I-VI.

Photodamaged Skin

Austin Institute for Clinical Research34 participantsStarted Jun 2023

Pflugerville, Texas, United States

Investigator Initiated Trial to Study Duobrii® Lotion in the Treatment of Mild Plaque Psoriasis in Adults

Proof of Concept Study to Access Superficial Basal Cell Carcinoma in Adults

Placebo-Controlled Study Assessing the Use of a Novel Exfoliative Serum With A Chemical Peel to Improve Photodamage in Adults

Find Trials by Condition in Texas

Safety and Efficacy of ARQ-252 Cream 0.3% in Subjects With Non-Segmental Facial Vitiligo

Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma

Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC.

Evaluating the Safety and Efficacy of the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE for Treatment of Acute Pulmonary Embolism

A Study to Learn How the Body Processes the Study Medicine Called PF-07923568 in People With Loss of Kidney Function

A Study of the Safety and Tolerability of LPCN 1144 in Subjects Who Completed the LPCN 1144-18-002 Trial

Open-label, Uncontrolled Phase II Trial of Intravenous PI3K Inhibitor BAY80-6946 in Patients With Relapsed, Indolent or Aggressive Non-Hodgkin's Lymphomas

Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Osteoarthritis

Pepinemab in Treating Younger Patients With Recurrent, Relapsed, or Refractory Solid Tumors

Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis

Oral Nutritional Supplementation in Children at Risk of Undernutrition

Belimumab Assessment of Safety in SLE

Study to Evaluate the Efficacy Safety and Tolerability of Ultevursen in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene (Sirius)

A Study of the Safety, Efficacy, and Biomarker Response of BMS-986165 in Participants With Moderate to Severe Ulcerative Colitis

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

C-myc Biomarker Study for Diabetic Foot Ulcers

Rilzabrutinib for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine